Policy Regarding Use of Dup15q Alliance Trademarks
The trademarks, logos, and service marks (“Marks”) displayed on this website, and related websites belonging to Dup15q Alliance, including the Dup15q Alliance logo, among others, are trademarks of the Dup15q Alliance, are the property of Dup15q Alliance, and are protected. Their uses are restricted to those programs and events sponsored by Dup15q Alliance, and Dup15q Alliance trademarks may not be used for personal financial gain. Use of the Marks is prohibited without the express written consent of Dup15q Alliance. Nothing contained on the Site should be construed as granting, by implication, estoppel, or otherwise, any license or right to use the Marks without the express written consent of Dup15q Alliance.
At times, Dup15q Alliance may grant limited-use licensing agreements to those individuals or groups who wish to help further the mission of Dup15q Alliance. Solely at the discretion of Dup15q Alliance, limited permission for use of Dup15q Alliance’s Marks may be granted for those projects which provide a substantial benefit to Dup15q Alliance or the chromosome 15q duplication syndrome community in general. For consideration, please submit, in writing, a letter of intent, which details how the Dup15q Alliance’s Marks will be used, the length of time they will be used, and the benefit of the project to Dup15q Alliance or the chromosome 15q duplication syndrome community to firstname.lastname@example.org at least 45 days prior to launch. Letters of intent may also be sent to: Dup15q Alliance, PO Box 674, Fayetteville, NY 13066, or send an e-mail to email@example.com.
Dup15q Alliance, P.O. Box 674, Fayetteville, NY 13066 USA
Shafali Jeste and Scott Dindot join Dup15q Alliance Professional Advisory Board
We are very pleased to announce that Shafali Jeste and Scott Dindot have agreed to join our Professional Advisory Board.
Dr. Shafali Jeste is a behavioral child neurologist who was recently recruited to UCLA as an Assistant Professor in Psychiatry and Neurology. After earning a BA in philosophy from Yale University in 1997 and her MD from Harvard Medical School in 2002, Dr. Jeste completed a residency in child neurology and a fellowship in behavioral child neurology at Boston Children's Hospital. From 2007-2009 she pursued post-doctoral training in developmental cognitive neuroscience with Dr. Charles Nelson at Harvard Medical School, where she gained expertise in the use of high density event related EEG and eye tracking to understand cognition in infants and toddlers with developmental disorders. Dr. Jeste has been the recipient of the Child Neurology Foundation's Rsearcher-in-Training Award (2007) and the American Academy of Neurology's Clinical Researcher-in-Training Award (2008). Through this funding she designed and implemented an ongoing study investigating neural correlates of autism in infants and toddlers with Tuberous Sclerosis Complex. At UCLA, she works in the Center for Autism Research and Treatment (CART) as a clinician and translational researcher. She directs the electrophysiology core within CART. Her reserach is focused on the design and application of novel, brain-based methods to better characterize behavioral and cognitive domains in infants at risk for autism and in young children with autism, and to determine how these domains predict clinical outcomes. She also has a special interest in evaluating and treating children with neurogenetic syndromes that confer a high risk of developmental disabilities, such as dup15q.
Dr. Scott Dindot is an Assistant Professor at Texas A&M University where he holds appointments in the Department of Pathobiology in the College of Veterinary Medicine & Biomedical Sciences and in the Department of Molecular and Cellular Medicine in the College of Medicine. He received his doctorate degree in genetics from Texas A&M University where his research focused on the study of genomic imprinting and epigenetics. He performed his postdoctoral training at Baylor College of Medicine as a NIH Fellow under the guidance of Dr. Arthur Beaudet where he studied mechanisms regulating genomic imprinting of the Prader-Willi/Angelman syndrome imprinted domain. The overarching goals of Dr. Dindot's research program at Texas A&M University are to understand the mechanisms regulating imprinted gene expression and the role of genomic structural variants in disease and common traits.
Click here for a list of other Professional Advisory Board members.